| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |